Indications |
Intravenous Muscle relaxant in general anaesthesia, Facilitate endotracheal intubation Adult: Initial dose: 80-100 mcg/kg. Subsequent doses: 10-20 mcg/kg. Initial dose following suxamethonium admin or in patients at high risk: 50-60 mcg/kg. Initial dose for caesarean section: 35 mcg/kg. Special Populations: Reduce dose to 50 mcg/kg body wt in patients with renal impairment and CrCl <40 mL/min. |
Contraindications |
Hypersensitivity. |
Warnings / Precautions |
Pulmonary disease, respiratory insufficiency, asthma, neuromuscular disease, dehydration, severely ill patients, hepatic or renal impairment. Doses in obese patients should be based on patient's ideal body weight. Pregnancy, lactation. |
Adverse Reactions |
Transient hypotension, bradycardia, reduced cardiac output. Potentially Fatal: Anaphylactic reactions and malignant hyperthermia. |
Overdose Reactions |
Prolonged apnoea due to paralysis of the intercostal muscles and diaphragm, with CV collapse and effects of histamine release. |
Drug Interactions |
Actions antagonised by cholinesterases and long term carbamazepine, phenytoin or corticosteroids usage. Enhanced block when used with drugs that have neuromuscular blocking activity such as lidocaine, quinidine, verapamil and aminoglycosides. Potentially Fatal: Effects enhanced by volatile inhalational anaesthetics, ketamine (IV), antiarrhythmics, antibacterials, K depleting diuretics, parenteral Mg salts. See Below for More pipecuronium Drug Interactions |
Mechanism of Actions |
Pipecuronium bromide is an aminosteroidal competitive neuromuscular blocker. It does not have significant CV adverse effects or histamine-related effects. Onset: Dose-dependent: 2.5-3 min. Duration: Dose-dependent: 30 min-2 hr. Distribution: Vd: 0.25 L/kg. Metabolism: Converted to 3-desacetyl (less active). Excretion: Via urine (as unchanged); 1.7-2.3 hr (elimination half-life). |
ATC Classification |
M03AC06 - pipecuronium bromide ; Belongs to the class of other quaternary ammonium-containing agents used as peripherally-acting muscle relaxants. |
Available As |
|
Pipecuronium
Post Review about Pipecuronium Click here to cancel reply.
Pipecuronium Containing Brands
Pipecuronium is used in following diseases
Drug - Drug Interactions of Pipecuronium
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.